Hemlibra
NHS England to fund Hemlibra for patients with severe haemophilia
August 21, 2019Research and Development Chugai, Hemlibra, Roche, haemophilia, pharma
NHS England is to fund Roche and Chugai Pharma UK’s haemophilia drug Hemlibra, for people with sever congenital haemophilia A …
Roche and Chugai’s Hemlibra scoops up EU approval in the prevention of severe haemophilia A without factor VIII inhibitors
March 14, 2019Sales and Marketing Chugai, Hemlibra, Roche, haemophilia, pharma
Roche has announced along with its partner Chugai that Hemlibra (emicizumab) has secured approval from the European Commission as a …
Hemlibra shows “clinically meaningful” bleed control in paediatric haemophilia A patients
December 4, 2018Manufacturing and Production, Research and Development ASH 2018, Hemlibra, Roche, haemophilia, pharma
In another reveal at the American Society of Hematology (ASH) Annual Meeting 2018, Roche unveiled new Phase 3 findings for …
FDA expands indication of Roche’s Hemlibra in haemophilia
October 5, 2018Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma
The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …
Roche’s Hemlibra stakes claim to be haemophilia market leader
May 21, 2018Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical
Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …
Top Ten most popular articles on Pharmafile.com this week
March 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten
As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …
Five deaths linked to Roche’s haemophilia drug Hemlibra
March 28, 2018Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma
Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its …
Europe approves first therapy for haemophilia A with inhibitors in over 20 years
March 1, 2018Research and Development Europe, European Commission, Hemlibra, Roche, haemophilia, pharma
Roche has revealed that its bispecific factor IXa- and factor X-directed antibody Hemlibra (emicizumab) has been approved by the European …
Roche’s haemophillia A treatment gets nod but with black box warning
November 17, 2017Medical Communications, Sales and Marketing Hemlibra, Roche, biotech, drugs, pharma, pharmaceutical
Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …
Latest content
